Ozempic/Wegovy Tracker App
Track Your Ozempic/Wegovy Protocol
Ozempic/Wegovy (Semaglutide) is a glp-1 agonist, FDA approved, used in STEP-1 with 14.9% weight loss at 68 weeks. Shotlee is the free app to track your complete Ozempic/Wegovy protocol — doses, side effects, weight, and labs.
What Is Ozempic/Wegovy?
Ozempic/Wegovy (Semaglutide) is a glp-1 agonist, FDA approved, used in STEP-1 with 14.9% weight loss at 68 weeks. Shotlee is the free app to track your complete Ozempic/Wegovy protocol — doses, side effects, weight, and labs.
Shotlee tracks every aspect of your Ozempic/Wegovy protocol: injection dates, doses, sites, side effects, weight changes, and lab results. Whether you are starting or optimizing, clean data makes better decisions.
What to Track in Shotlee
Build a complete Ozempic/Wegovy protocol record from day one.
How to Track Your Ozempic/Wegovy Protocol
Ozempic/Wegovy Key Facts
Protocol FAQs
Yes! Shotlee fully supports compounded semaglutide with custom dosing. Enter any mg amount and track vials, reconstitution, and more.
Absolutely! Shotlee supports Rybelsus daily tablet tracking with 3mg, 7mg, and 14mg doses, plus reminders to take it on an empty stomach.
Log each injection with your current dose. Shotlee shows your dose history and helps you track your titration schedule from starting to maintenance dose.
Open the Shotlee app, navigate to the dose logging screen, select Semaglutide as your medication, and enter the dose amount, injection site, and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts. The app is free to download and use.
The most important side effects to track include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), injection site reactions, appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider at your next visit.
Most patients begin noticing appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule and individual metabolic response. Track your weekly weight in Shotlee to visualize your personal response curve over time.
Track Your Ozempic/Wegovy Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.
📚References & sources
Latest on Semaglutide
Alli Weight Loss Pill: FDA Flags Serious Kidney Risks
The Food and Drug Administration (FDA) has issued a new warning regarding potential serious kidney complications associated with Alli, the sole over-the-counter weight loss medication available in the United States. The drug's label has been updated to reflect these risks, urging caution for consumers.
8 min read
Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure
GLP-1 receptor agonists, known for their role in diabetes and weight management, are increasingly recognized for their broader health benefits, including effects on blood pressure. This article delves into how these medications work, their impact on cardiovascular health, and whether they are safe for individuals with hypertension.
8 min read
Wegovy Pill Arrives in the UK: A New Era for Weight Management?
The UK has officially approved a pill version of the popular Wegovy weight-loss drug, marking a significant advancement in accessible obesity treatment. This development offers a convenient alternative to weekly injections for many.
6 min read